Harmony Biosciences Holdings, Inc.
HRMY
$38.12
-$0.38-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.25% | 20.71% | 21.51% | 21.13% | 17.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.25% | 20.71% | 21.51% | 21.13% | 17.74% |
| Cost of Revenue | 40.98% | 30.71% | 26.48% | 26.55% | 23.88% |
| Gross Profit | 19.63% | 17.95% | 20.11% | 19.66% | 16.15% |
| SG&A Expenses | 14.20% | 19.10% | 22.95% | 10.12% | 13.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.43% | 29.06% | 25.97% | 18.50% | 15.20% |
| Operating Income | 3.96% | -2.83% | 9.25% | 28.72% | 24.58% |
| Income Before Tax | 7.13% | 0.19% | 12.13% | 31.44% | 36.45% |
| Income Tax Expenses | 35.49% | 16.82% | 21.74% | -15.04% | -11.54% |
| Earnings from Continuing Operations | 0.20% | -4.65% | 9.07% | 51.42% | 57.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.20% | -4.65% | 9.07% | 51.42% | 57.32% |
| EBIT | 3.96% | -2.83% | 9.25% | 28.72% | 24.58% |
| EBITDA | 4.17% | -1.89% | 8.78% | 25.03% | 21.35% |
| EPS Basic | -0.83% | -5.54% | 8.01% | 50.86% | 59.96% |
| Normalized Basic EPS | 6.05% | -0.76% | 10.99% | 30.97% | 31.12% |
| EPS Diluted | -0.55% | -5.23% | 8.10% | 50.85% | 59.14% |
| Normalized Diluted EPS | 6.35% | -0.59% | 10.87% | 30.47% | 30.20% |
| Average Basic Shares Outstanding | 0.96% | 1.05% | 1.07% | 0.29% | -1.30% |
| Average Diluted Shares Outstanding | 0.72% | 0.96% | 1.25% | 0.77% | -0.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |